We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.76B
1-Year Est. Return
62.41%
This Fund
S&P 500
This Quarter
Est. Return
+4.17%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$10.3B
AUM Growth
+$4.59B
(+80%)
Cap. Flow
+$3.41B
Cap. Flow
% of AUM
32.95%
Top 10 Holdings %
Top 10 Hldgs %
18.2%
Holding
970
New
347
Increased
294
Reduced
63
Closed
219
Avg Time Held Equity + Options
1.3
quarters
Top 10 Avg Time Held Equity + Options
1
quarter
Top 20 Avg Time Held Equity + Options
1.6
quarters
Avg Time Held Equity only
1.3
quarters
Top 10 Avg Time Held Equity only
1
quarter
Top 20 Avg Time Held Equity only
1.6
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$230M |
| 2 |
NLSN
Nielsen Holdings plc
NLSN
|
+$110M |
| 3 |
Brightstar Lottery PLC
BRSL
|
+$98M |
| 4 |
FDO
FAMILY DOLLAR STORES
FDO
|
+$96.8M |
| 5 |
GE Aerospace
GE
|
+$92.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$142M |
| 2 |
PROTECTIVE LIFE CORP
PL
|
+$135M |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$129M |
| 4 |
AGN
Allergan Inc
AGN
|
+$97.8M |
| 5 |
CVD
COVANCE INC.
CVD
|
+$84.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 20.85% |
| 2 | Industrials | 15.86% |
| 3 | Consumer Discretionary | 15.68% |
| 4 | Consumer Staples | 11.68% |
| 5 | Technology | 8.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
701
PUT
First Horizon
FHN
$10.9B
| $10K | ﹤0.01% |
+40,400
| New | +$557K |
2015 Q1
0 quarters
|
|
702
PUT
DELISTED
Chesapeake Energy Corporation
CHK
| $10K | ﹤0.01% |
+2,000
| New | +$7.06M |
2015 Q1
0 quarters
|
|
703
PUT
Carnival Corporation Ltd
CCL
$35.9B
| $8K | ﹤0.01% |
+50,600
| New | +$2.28M |
2015 Q1
0 quarters
|
|
704
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$822B
| $6K | ﹤0.01% |
120,000
-680,000
| -85% | -$140M |
2014 Q4
1 quarter
|
|
705
Autodesk
ADSK
$48.9B
| – | – |
-5,543
| Closed | -$333K | – |
|
706
AES
AES
$10.7B
| – | – |
-19,381
| Closed | -$267K | – |
|
707
American Financial Group
AFG
$11.8B
| – | – |
-6,284
| Closed | -$382K | – |
|
708
AGCO
AGCO
$7.25B
| – | – |
-225,000
| Closed | -$10.2M | – |
|
709
American International
AIG
$40.4B
| – | – |
-4,003
| Closed | -$224K | – |
|
710
Akamai
AKAM
$14.6B
| – | – |
-69,234
| Closed | -$4.36M | – |
|
711
Alto Ingredients
ALTO
$282M
| – | – |
-230,000
| Closed | -$2.38M | – |
|
712
ANI Pharmaceuticals
ANIP
$1.68B
| – | – |
-46,773
| Closed | -$2.64M | – |
|
713
Arrow Electronics
ARW
$11.5B
| – | – |
-5,590
| Closed | -$324K | – |
|
714
A10 Networks
ATEN
$2.12B
| – | – |
-152,586
| Closed | -$665K | – |
|
715
Axalta
AXTA
$7B
| – | – |
-66,000
| Closed | -$1.72M | – |
|
716
AstraZeneca
AZN
$245B
| – | – |
-88,398
| Closed | -$6.22M | – |
|
717
Boeing
BA
$150B
| – | – |
-3,642
| Closed | -$473K | – |
|
718
Baxter International
BAX
$12.7B
| – | – |
-15,682
| Closed | -$624K | – |
|
719
Brown & Brown
BRO
$21.3B
| – | – |
-13,744
| Closed | -$226K | – |
|
720
Boston Scientific
BSX
$62.6B
| – | – |
-24,302
| Closed | -$322K | – |
|
721
DELISTED
Cadence Bank
CADE
| – | – |
-82,431
| Closed | -$1.86M | – |
|
722
Caterpillar
CAT
$372B
| – | – |
-4,000
| Closed | -$366K | – |
|
723
CBRE Group
CBRE
$38B
| – | – |
-7,341
| Closed | -$251K | – |
|
724
Crown Holdings
CCK
$11.9B
| – | – |
-9,198
| Closed | -$468K | – |
|
725
Church & Dwight Co
CHD
$23.6B
| – | – |
-24,000
| Closed | -$946K | – |
|
Similar funds
FNBT
ACI
RC
A
CGL
CB
JCM
MPM
UBS O'Connor's Q1 2015 Portfolio in Review
As of Q1 2015, UBS O'Connor held 970 positions worth $10.3B, up 80% from $5.75B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS O'Connor deployed $3.41B of net new capital in Q1 2015, opening 347 new positions and adding to 294 existing holdings. Its largest new stake was SALIX PHARMACEUTICALS LTD DEL: 1,567,292 shares worth $271M.
By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, down from 21% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Humana, an estimated $57.6M trimmed.
- UBS O'Connor's largest Q1 2015 buy was SALIX PHARMACEUTICALS LTD DEL: 1,567,292 shares worth $271M.
- UBS O'Connor added most to Nielsen Holdings plc in Q1 2015, an estimated $110M increase.
- UBS O'Connor's biggest Q1 2015 reduction was Humana, cutting an estimated $57.6M.
- UBS O'Connor fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $142M.
- UBS O'Connor's ten largest holdings make up 18% of its $10.3B portfolio in Q1 2015.
- UBS O'Connor opened 347 new positions and closed 219 in Q1 2015.
- UBS O'Connor's portfolio value rose 80% quarter-over-quarter to $10.3B.
Based on UBS O'Connor's 13F filing for Q1 2015, filed 14 May 2015.